NewLink Genetics Presents Phase 1 Data Supporting Significantly Higher Exposure with Indoximod Prodrug, NLG802, and Biomarker Data from Two Phase 2 Trials Illustrating Indoximod’s Impact on the Tumor Microenvironment at SITC 2018

World News: . []

AMES Iowa Nov 09 2018 GLOBE NEWSWIRE -- NASDAQNLNK announced that data from three LINK  trials are being presented at the LINK  for Immunotherapy of Cancer SITC Annual LINK  in Washington DC Data from a Phase 1a clinical trial of NLG...

More news and information about NewLink Genetics Corporation

Published By:

Globe Newswire: 13:00 GMT Friday 9th November 2018

Published: .

Search for other references to "newlink" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us